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FREE URETERAL REPLACEMENT IN RATS: 
REGENERATION OF URETERAL WALL COMPONENTS 
IN THE ACELLULAR MATRIX GRAFT 
STEFAN E. DAHMS, HANS J. PIECHOTA, LORA NUNES, RAJVIR DAHIYA, TOM F. LUE, 
AND EMIL A. TANAGHO 
ABSTRACT 
Objectives. To evaluate ureteral replacement by a free homologous graft of acellular matrix in a rat model. 
Methods. In 30 male Sprague-Dawley rats, a 0.3 to 0.8-cm midsegment of the left ureter was resected and 
replaced with an acellular matrix graft of equal length placed on a polyethylene stent. The animals were killed 
at varying intervals, and the grafted specimens were prepared for light and electron microscopy. 
Results. In all animals, the acellular matrix graft remained in its original position without evidence of incrus- 
tation or infection, and histologic examination showed complete epithelialization and progressive infiltration 
by vessels. At 10 weeks, smooth muscle fibers were observed; at 12 weeks, nerve fibers were first detected; 
at 4 months, smooth muscle cells had assumed regular configuration. 
Conclusions. The ureteral acellular matrix graft appears to promote the regeneration of all ureteral wall 
components. UROLOGY 50: 818-825, 1997. 0 1997, Elsevier Science Inc. All rights reserved. 
U reteral replacement has long been a subject of interest to researchers, and many surgical 
procedures and materials have been tried.le4 
However, an entirely satisfactory method has yet 
to be found. Previous research has demonstrated 
that collagen-based materials, such as porcine 
small intestine submucosa (SIS), have the best 
potential regenerative capability.5 In this group of 
biomaterials, a new acellular matrix has recently 
been shown, in the bladder of the rat model, to 
serve as a scaffold consisting of collagen and elas- 
tin fibers for the ingrowth of all bladder wall com- 
ponents.6’7 In addition, the contractility of graft- 
regenerated bladders has been observed in vivo 
(preliminary results). We designed the present 
study to determine whether this acellular matrix 
could be used as a free ureteral graft in a rat 
model. 
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MATERIAL AND METHODS 
ANIMALS AND SURGICAL TECHNIQUE 
Male Sprague-Dawley rats (n = 301, weighing 260 to 360 
g, were housed three to a cage at constant temperature and 
humidity with a 12-hour light and dark cycle. Rats were 
given free access to standard labaratory chow and tap water. 
The technique for preparation of the matrix graft, described 
previously for the bladder,’ was modified as follows: the ure- 
ter from a Sprague-Dawley rat was excised and placed on a 
polyethelene stent (inner diameter [ID] 0.28 mm; outer di- 
ameter [OD] 0.61 mm) for further processing. Because the 
tiny rat ureter is not suitable for inversion, for the ureteral 
matrix the mucosa was not scraped off as it was in the prcp- 
aration of the bladder matrix graft. Partial cell lysis (in 10 
mM PBS), complete cell lysis (in 1 M sodium chloride con- 
taining 2000 Kunitz units DNase), and solubilizing of the 
lipid membranes in 50 mL of 4% sodium desoxycholate con- 
taining 0.1% sodium azide (repeated once) were performed. 
The resulting ureteral acellular matrix graft was stored in 
10% neomycin sulfate at 4°C until grafted (Fig. 1). 
At the time of surgery, animals were anesthetized with 
sodium pentobarbital (6 mg/lOO g body weight intraperito- 
neally) and, through a midline lower abdominal incision, the 
left ureter was exposed. A 0.3 to 0.8~cm midsegment of the 
ureter was resected and replaced with an equal graft segment 
placed on a polyethylene stent through the open ends of the 
host ureter (Fig. 2). The stent was used to prevent obstruc- 
tion at the level of the graft. The graft segment was trimmed 
to confor-m to the remaining host ureter and sutured in place 
with monofilament 10.0 nonabsorbable Dermalon sutures to 
identify the matrix borders. To promote growth, the acel- 
lular matrix graft was surrounded with retroperitoneal fat. 
When satisfactory closure was achieved, the abdominal wall 
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FIGURE 1. Photographic documentation of a rat ureter placed on a polyethylene stent before (A) and after 
processing into a ureteral acellular matrix graft. 
FIGURE 2. Surgical procedure of partial ureteral replacement by the ureteral acellular matrix graft: (A) exposure 
and temporary clamping of the left ureter; (B) ureterotomy and intubation by the stented graft in the direction of the 
urinary bladder (arrows); (C) distal anastomosis with interrupted sutures; (0) intraoperative view after implantation. 
and the skin were closed. For microsurgery, an Olympus under a dissecting microscope, and collected. All speci- 
binocular operating microscope (10X to 40X) was used. No mens were rinsed with saline solution to remove excess 
drugs were administered postoperatively. intraluminal urine. Tissues were fixed at the time of acces- 
sion and processed for light and transmission electron mi- 
LIGHTMICROSCOPICAND ULTRASTRUCTURAL 
croscopy. 
Light Microscopy. Specimens were fixed in 10% buffered 
EVALUATION formalin for at least 24 hours. After dehydration in graded 
The animals were killed at the following times: 4 days (n ethanol solutions, the specimens were embedded in paraffin, 
= 3), 3 weeks (n = 5), 6 weeks (n = 31, 10 weeks (n = sectioned (5 pm), and stained with trichrome for collagen 
7), 3 months (n = 5), and 4 months (n = 5). Host ureter and smooth muscle, hematoxylin and eosin (H Q E) for nu- 
and graft were identified, freed from the surrounding tissue clei, alpha-actin for smooth muscle, and protein gene prod- 
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FIGURE 3. Confirmation of the acellularity of the ma- 
trix graft and its structure as a framework of elastin 
and collagen fibers: (A) H & E staining at an original 
magnification of x200; (B) scanning electron micros- 
copy at low magnification (original magnification x25) 
shows the intact surface of the ureteral acellular ma- 
trix; (C) at higher magnification (original magnification 
x 130), the mesh-like structure of fibers (which may 
serve as a scaffold), without evidence of cellular ele- 
ments, is demonstrated. 
uct 9.5 (PGP 9.5) for nerves. The monoclonal antibody anti- 
alpha-smooth muscle actin recognizes alpha-smooth musle 
cells exclusively.* Protein gene product 9.5 represents a ma- 
jor protein component of the neural cytoplasm and therefore 
labels more nerve fibers than other general nerve markers.9~‘0 
Before implantation, pure graft specimens were also pre- 
pared for light and scanning electron microscopy to confirm 
the structure as an acellular scaffold consisting of collagen 
and elastin fibers and thus the effectiveness of the matrix 
preparation process. 
Transmission Electron Microscopy. Specimens were im- 
mersed in a fixative (2.5% glutaraldehyde and 2.5% parafor- 
maldehyde) in 0.15 M sodium cacodylate buffer. After the 
primary fixation, the samples were placed in a drop of fixa- 
m 
U-AMG 10 weeks tx). . 
L I 
FIGURE 4. Macroscopic view of the rat ureteral matrix 
graft 10 weeks after surgery. Arrows mark nonabsorb- 
able sutures to identify the border between the matrix 
graft and host. 
tive on dental wax and cut in approximately 3-mm segments. 
Specimens were postfixed with 2% osmium tetroxide, block 
stained in 2% uranyl acetate, and dehydrated in a graded 
series of ethanol and propylene oxide, after which they were 
embedded in resin. Thin sections (500 A) were obtained, 
mounted on 200-mesh copper grids, stained in uranyl ace- 
tate and lead citrate, and examined in a Zeiss Model 1Oc 
electron microscope. 
RESULTS 
MORTALITY 
Of the 30 animals, 2 died 6 weeks after surgery 
from a coronavirus infection associated with se- 
vere respiratory tract obstruction and were not 
used for further microscopic evaluation. In con- 
trast to our reported experience with the matrix 
grafted to the bladder,7 stone formation was not 
observed in either the upper or lower urinary tract. 
EVALUATION OF MATRIX TECHNIQUE 
Light microscopy of the pure ureteral matrix 
demonstrated the effectiveness of the matrix prep- 
aration process. The acellularity of the graft as an 
intact framework consisting of elastin and collagen 
fibers was apparent (Fig. 3A). Scanning electron 
microscopy showed the intact nature of the ure- 
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A. U-AMG 4 days p.o. 
C. U-AMG 10 weeks p.o. 
B. U-AMG 3 weeks p.o. 
D. U-AMG 4 months p.o. 
FIGURE 5. Step-by-step regeneration of ureteral wall components (Masson’s trichrome stain, original magnification 
x200). After infiltration of erythrocytes and mononuclear ceils (arrow) (A), urothelium (arrow) begins to develop in 
the first weeks (B). At 10 weeks (C), the first few muscle fibers are seen (arrow), and after 4 months (D), a complete 
regeneration of urothelium and muscularization can be observed (arrow marks borderline (suture] between the matrix 
graft [left] and the host ureter [right]) (U-AMG, ureteral acellular matrix graft). 
teral matrix surface and confirmed the scaffold- 
like structure of the graft without evidence of cell- 
ular elements (Fig. 3B, C). 
MACROSCOPIC APPEARANCE OF EXPLANTED GRAFTS 
Moderate adhesions were noted to the surround- 
ing retroperitoneal fat. The graft remained in its 
original position in all animals, without evidence 
of incrustation or infection (Fig. 4), whereas the 
polyethylene tube migrated to the distal ureter. 
For this reason, gross examination of all surgical 
specimens revealed varying degrees of hydroure- 
teronephrosis to the level of the graft. There was 
no evidence of postoperative urinary leakage in 
any of the animals at death. 
UROLOGY 50 (5), 1997 
LIGHT MICROSCOPY 
Histologic examination of all graft-regenerated 
ureters showed step-by-step regeneration of uro- 
thelium and smooth muscle fibers (Fig. 5). At 4 
days, the graft showed an infiltration of erythro- 
cytes and mononuclear cells, and the urothelial 
lining appeared to begin to bridge the matrix graft. 
At 10 weeks, the graft was composed of several 
layers of urothelium and some capillaries, and 
characteristic arrangements of smooth muscle fi- 
bers (Fig. 6) were first observed. The number of 
vascular elements (capillaries) had increased. At 
12 weeks, nerve regeneration was first detected by 
PGP 95positive staining (Fig. 7). At 4 months, 
neomuscularization was well developed. The 
821 
months p.0.) 
FIGURE 6. Histologic appearance of the ureteral acel- 
War matrix graft (U-AMC) 3 months after grafting. 
Smooth muscle cell differentiation is confirmed by local- 
ization of alpha-actin (original magnification x300). 
Note the opaquely stained thick strands, which repre- 
sent alpha-actin smooth muscle fibers (arrow). 
smooth muscle cells were arranged in parallel rows 
in the longitudinal direction. The thickness of 
these muscle bundles seemed to decrease in the 
central part of the graft. There was no sign of de- 
generative change such as calcification or necrosis 
of the smooth muscle layer. The urothelial lining, 
differentiated muscularization, and surrounding 
fibrous adventitia appeared qualitatively similar to 
normal ureteral wall components (see below). In 
contrast, we noted that the number of nerve fibers 
was less than in the normal ureter. 
ELECTRON MICROSCOPY 
Smooth muscle regeneration in the grafted 
ureteral matrix was confirmed by transmission 
electron microscopy (Fig. 8). At 3 months, spec- 
imens demonstrated a lower density of myofila- 
ments in the graft than in the normal rat ureter. 
At 4 months, the number of myofilaments was 
significantly increased. These observations cor- 
responded to the light microscopic findings at 
the same time. Nerve regeneration was con- 
firmed in 4-month specimens studied by elec- 
tron microscopy (Fig. 9). Although the number 
of nerve fibers in the matrix graft was notably 
less than in the normal ureter, their morphologic 
characteristics were similar. 
COMMENT 
Ureteral replacement has long been a challenge 
for urologists. In other specialties, the success 
FIGURE 7. PCP 9.5 staining of normal ureter (A) and 
graft 3 months postoperatively (B). Nerve regeneration 
is confirmed (original magnification x400). Note the 
lower density of PGP 9.5-positive nerve staining in the 
graft (arrow) (U-AMG, ureteral acellular matrix graft). 
of acellular matrix grafts for organ substitution 
has been reported (eg, replacement of heart 
valves, coronary artery bypass, and, in particular, 
skin).‘l-14 Although the concept of free grafts 
to treat ureteral diseases is not new, none of the 
materials previously reported has been able to 
satisfy all the criteria for the ideal substitute 
(Table I).15-24 In the present study, complete 
epithelialization, angiogenesis, and regeneration 
of smooth muscle fibers and nerves were observed 
with no signs of rejection. 
The reasons for the improved acceptance of the 
ureteral acellular matrix graft over that of other 
free ureteral transplants are still unknown. In ac- 
cordance with our previous experience, we used 
extremely fine nonabsorbable suture material to 
minimize immediate postoperative inflammatory 
reactions, which can result in incrustation or stone 
formation. Rapid epithelialization, progressive 
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A. 
FIGURE 8. Transmission electron microscopy of normal ureter (A and B) and graft 3 months postoperal 
D) (origin 7al magnification x 13,500). Note lower density of myofilaments (M) in the graft-regenerated ral 
in the no Irm al ureter. Mitochondria (m) are also seen (U-AMG, ureteral acellular matrix graft). 
:ively (C : and 
: ureter than 
neoangiogenesis, and continuous smooth muscle 
regeneration, apparently arising from the adjacent 
edges of the host ureter, are possible factors re- 
sponsible. Expression of growth factors seems to 
play a key role in the mechanisms controlling ep- 
ithelialization.25 In our research, studies of trans- 
forming growth factor (TGF) expression in the rat 
bladder acellular matrix graft showed variable in- 
duction of TGFa, TGFPr, TGFP2, and TGF& 
transcription, with prominent mRNA expression 
of TGFa and TGF& (preliminary results). 
In time, early smooth muscle cells matured into 
normal-appearing smooth muscle bundles. Be- 
cause smooth muscle production has been re- 
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ported from pericytes after capillary neovascular- 
ization,26 we hypothesize on the basis of our 
studies that the source of smooth muscle fibers in 
the acellular matrix graft is the adjacent edges of 
the host ureter. Regulating mechanisms of smooth 
muscle differentation are poorly understood. Be- 
sides growth factor expression (as just men- 
tioned), epithelial-mesenchymal interactions are 
thought to be important for smooth muscle regen- 
eration. In 1961, Taderera2’ demonstrated that the 
absence of lung epithelium causes failure of both 
smooth muscle and cartilage differentation. Con- 
sistent with these results, Baskin et aL2* reported 
in 1996 that intact bladder as well as isolated blad- 
823 
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FIGURE 9. Transmission electron microscopy of nor- 
mal ureter (A) and graft 4 months postoperatively (B) 
(original magnification ~50,000). The graft-regener- 
ated rat ureter shows morphologically intact nerves with 
axons (Ax), mitochondria (m), neurotubules (Nt), neu- 
rofilaments (Nt), and Schwann cell sheath (SW) (U-AMC, 
ureteral acellular matrix graft). 
der mesenchyme recombined with bladder uro- 
thelium from rat fetuses, when grafted under the 
renal capsule of adult rats, demonstrated expres- 
sion of smooth muscle differentiation; however, 
grafts of bladder mesenchyme alone failed to in- 
duce smooth muscle differentiation. Therefore, 
early epithelialization in the graft may be highly 
important for smooth muscle differentation. 
The observation that the overall (PGP 95pos- 
itive) density of the reinnervation of the ureteral 
acellular matrix graft was significantly lower than 
that of the normal ureter may indicate that cell- 
derived factors are needed to achieve normal lev- 
TABLE I. Criteria for the ideal 
ureteral substitute * 
Close histologic resemblance to normal ureter 
Peristaltic activity synchronous with host ureter 
Adequate blood supply 
Free transport of urine 
Impermeable, nonabsorptive lining 
No immunologic reaction 
No stone formation 
Technical ease 
No stricture formation at the anastomotic site 
Normal innervation and adequate pharmacologic 
response 
* Summarized from Baum et al.’ 
els of innervation. A similar experience has been 
described by Gavazzi et a1.29 They showed that, 
after grafting of frozen and thawed acellular ce- 
rebral blood vessels in oculo, the reinnervation of 
the graft was less than that of the control, and 
PGP 95positive nerves appeared less dense on 
the transplants as well. However, in the present 
study regeneration of nerves was confirmed by 
light and electron microscopy and may increase 
over a longer period of time to achieve functional 
capacities. 
In conclusion, the ureteral acellular matrix 
graft appears to promote the regeneration of all 
ureteral wall components. These results may in- 
dicate that the graft has a potential for functional 
neomuscularization that will result in its main- 
tenance as a physiologic ureteral wall. Tube mi- 
gration with consequent obstruction at the level 
of the stent, causing hydroureteronephrosis, was 
not avoidable. It would thus be reasonable to un- 
dertake further study in a larger animal model. 
Detailed functional and molecular biologic ex- 
periments are needed to evaluate whether the 
ureteral acellular matrix graft as a ureteral sub- 
stitute can conduct peristaltic activity in coor- 
dination with the host components to preserve 
the functional integrity of the renal parenchyma. 
The findings of regenerated ureteral wall com- 
ponents are encouraging and support the clinical 
potential of the acellular matrix graft in genito- 
urinary tract reconstruction. 
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